Akiko Uenaka

2.2k total citations
70 papers, 1.7k citations indexed

About

Akiko Uenaka is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Akiko Uenaka has authored 70 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Immunology, 31 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Akiko Uenaka's work include Immunotherapy and Immune Responses (47 papers), T-cell and B-cell Immunology (26 papers) and Immune Cell Function and Interaction (23 papers). Akiko Uenaka is often cited by papers focused on Immunotherapy and Immune Responses (47 papers), T-cell and B-cell Immunology (26 papers) and Immune Cell Function and Interaction (23 papers). Akiko Uenaka collaborates with scholars based in Japan, United States and Australia. Akiko Uenaka's co-authors include Eiichi Nakayama, Toshiro Ono, Hisashi Wada, Midori Isobe, Yuji Noguchi, Heiichiro Udono, Mikio Oka, Lloyd J. Old, Hiroshi Shiku and Tsukasa Seya and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Akiko Uenaka

69 papers receiving 1.7k citations

Peers

Countries citing papers authored by Akiko Uenaka

Since Specialization

Citations

This map shows the geographic impact of Akiko Uenaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiko Uenaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiko Uenaka more than expected).

Fields of papers citing papers by Akiko Uenaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiko Uenaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiko Uenaka. The network helps show where Akiko Uenaka may publish in the future.

Co-authorship network of co-authors of Akiko Uenaka

This figure shows the co-authorship network connecting the top 25 collaborators of Akiko Uenaka. A scholar is included among the top collaborators of Akiko Uenaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiko Uenaka. Akiko Uenaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prolongation of Overall Survival in Advanced Lung Adenocarcinoma Patients with the XAGE1 (GAGED2a) Antibody 2014 ·Clinical Cancer Research ·Yoshihiro Ohue, Koji Kurose, (unknown), Hirofumi Matsumoto, (unknown), Midori Isobe, Minoru Fukuda, Akiko Uenaka, Mikio Oka, Eiichi Nakayama	20
2	Increase in Activated Treg in TIL in Lung Cancer and In Vitro Depletion of Treg by ADCC Using an Antihuman CCR4 mAb (KM2760) 2014 ·Journal of Thoracic Oncology ·Koji Kurose, Yoshihiro Ohue, Eiichi Sato, Akira Yamauchi, Shingo Eikawa, Midori Isobe, (unknown), Akiko Uenaka, Mikio Oka, Eiichi Nakayama	48
3	Production of NY-ESO-1 peptide/DRB108:03 tetramers and ex vivo detection of CD4 T-cell responses in vaccinated cancer patients 2014 ·Vaccine* ·(unknown), Akiko Uenaka, Midori Isobe, Hisashi Wada, Kazuhiro Kakimi, Takashi Saika, (unknown), (unknown), Mikio Oka, Eiichi Nakayama	2
4	A phase I study of vaccination with NY‐ESO‐1f peptide mixed with Picibanil OK‐432 and Montanide ISA‐51 in patients with cancers expressing the NY‐ESO‐1 antigen 2011 ·International Journal of Cancer ·Kazuhiro Kakimi, Midori Isobe, Akiko Uenaka, Hisashi Wada, Eiichi Sato, Yuichiro� Doki, Jun Nakajima, Yasuyuki Seto, Tomoki Yamatsuji, Yoshio Naomoto, Kenshiro Shiraishi, Nagio Takigawa, Katsuyuki Kiura, Kazuhide Tsuji, Keiji Iwatsuki, Mikio Oka, Linda Pan, Eric W. Hoffman, Lloyd J. Old, Eiichi Nakayama	66
5	Antibody response against NY‐ESO‐1 in CHP‐NY‐ESO‐1 vaccinated patients 2007 ·International Journal of Cancer ·Ryohei Kawabata, Hisashi Wada, Midori Isobe, Takashi Saika, Shuichiro Sato, Akiko Uenaka, Hiroshi Miyata, Takushi Yasuda, Yuichiro� Doki, Yuji Noguchi, Hiromi Kumon, Kazuhide Tsuji, Keiji Iwatsuki, Hiroshi Shiku, Gerd Ritter, Roger Murphy, Eric W. Hoffman, Lloyd J. Old, Morito Monden, Eiichi Nakayama	58
6	Identification of glioma‐specific RFX4‐E and ‐F isoforms and humoral immune response in patients 2005 ·Cancer Science ·Hirokazu Matsushita, Akiko Uenaka, Toshiro Ono, Kosei Hasegawa, Shuichiro Sato, (unknown), Kazuhiko Nakagawa, Masahiro Toda, Tetsuro Shingo, Tomotsugu Ichikawa, Yuji Noguchi, Takashi Tamiya, Tomohisa Furuta, Takeshi Kawase, Isao Date, Eiichi Nakayama	18
7	Inhibition of RL male 1 tumor growth in BALB/c mice by introduction of the RLakt gene coding for antigen recognized by cytotoxic T‐lymphocytes and the GM‐CSF gene by in vivo electroporation 2004 ·Cancer Science ·Motoyuki Tanaka, Masaharu Yamada, Toshiro Ono, Yuji Noguchi, Akiko Uenaka, (unknown), (unknown), Mine Harada, Mitsune Tanimoto, Eiichi Nakayama	4
8	Analysis of CD8 T‐cell response by IFNγ ELISPOT and H‐2L^d/ pRL1a tetramer assays in pRL1a multiple antigen peptide‐immunized and RL male 1‐bearing BALB/ c and (BALB/c×C57BL/6) F₁ mice 2004 ·Cancer Science ·(unknown), Yuji Noguchi, Akira Kenjo, Hisashi Wada, Akiko Uenaka, Teizo Fujita, Hajime Inoue, Eiichi Nakayama	2
9	Cryptic CTL Epitope on a Murine Sarcoma Meth A Generated by Exon Extension as a Novel Mechanism 2003 ·The Journal of Immunology ·Akiko Uenaka, (unknown), (unknown), Sanda Win, (unknown), Motoyuki Tanaka, Toshiro Ono, Jonathan Skipper, Kenji Shimizu, Eiichi Nakayama	6
10	Murine leukemia RL1 and sarcoma Meth A antigens recognized by cytotoxic T lymphocytes (CTL) 2003 ·Cancer Science ·Akiko Uenaka, Eiichi Nakayama	5
11	Sequential Involvement of Two Distinct CD4⁺ Regulatory T Cells during the Course of Transplantable Tumor Growth and Protection from 3–Methylcholanthrene‐induced Tumorigenesis by CD25–depletion 2002 ·Japanese Journal of Cancer Research ·Isao Tawara, Yutaka Take, Akiko Uenaka, Yuji Noguchi, Eiichi Nakayama	22
12	Molecular cloning and sequence analysis of the cDNA for the mouse counterpart to adult hamster liver purified growth inhibitory factor 1997 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·(unknown), Hiroaki Masuda, Masako Ayaki, Yasuhiko Suzuki, Akiko Uenaka, Tsukasa Seya, Jun Miyoshi, Katsuhito Takahashi, Yukiharu Inui	1
13	Double‐cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region 1997 ·Genes to Cells ·Naoki Shimbara, Hiroto Nakajima, Nobuyuki Tanahashi, (unknown), Shin‐ichiro Niwa, Akiko Uenaka, Eiichi Nakayama, Keiji Tanaka	54
14	Production of Murine Leukemia RL♂1 Rejection Antigen Peptide pRL1a by Proteolysis of Natural Precursor pRL1b 1996 ·Japanese Journal of Cancer Research ·Toshiro Ono, Akiko Uenaka, Eiichi Nakayama	4
15	Roles of CD8+ and CD4+ cells on lethal graft-versus-host disease in nude mice 1993 ·Transplant Immunology ·Akiko Uenaka, Kagemasa Kuribayashi, Eiichi Nakayama	1
16	Differential involvement of CD4+ cells in mediating skin graft rejection against different amounts of transgenic H-2K(b) antigen. 1991 ·The Journal of Experimental Medicine ·Minoru Kawai, Yuuki Obata, Noriyuki Hamasima, Tsuyoshi Takahashi, Akiko Uenaka, Morito Monden, Takahiro Mori, Hiroshi Shiku, Emi E. Nakayama	19
17	Participation of a dominant cytotoxic T cell population defined by a monoclonal antibody in syngeneic anti‐tumor responses 1990 ·European Journal of Immunology ·(unknown), Toshiyasu Hirama, (unknown), Michihiro Iwashiro, Tohru Masuda, Haruto Uchino, Sunao Takeshita, Hideo Yamagishi, Heiichiro Udono, (unknown), (unknown), Hiroshi Shiku, Akiko Uenaka, Kagemasa Kuribayashi	12
18	THE MECHANISM OF DISCORDANT XENOGRAFT REJECTION 1988 ·Transplantation ·Shuji Miyagawa, Hajime Hirose, Ryota Shirakura, (unknown), Seizoh Nakata, Yasunaru Kawashima, Tsukasa Seya, Misako Matsumoto, Akiko Uenaka, Hajime Kitamura	194
19	Effector cells in allelic H-2 class I-incompatible skin graft rejection. 1987 ·The Journal of Experimental Medicine ·T. Ichikawa, Eiichi Nakayama, Akiko Uenaka, Morito Monden, Taketoshi Mori	37
20	Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejection. 1985 ·The Journal of Experimental Medicine ·Eiichi Nakayama, Akiko Uenaka	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact